Harmony Biosciences Holdings, Inc. (HRMY)
36.13
+0.10
(+0.28%)
USD |
NASDAQ |
Oct 23, 16:00
36.07
-0.06
(-0.17%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap : 2.100B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.100B |
| October 22, 2026 | 2.094B |
| October 21, 2026 | 2.227B |
| October 20, 2026 | 2.249B |
| October 19, 2026 | 2.182B |
| October 16, 2026 | 2.206B |
| October 15, 2026 | 2.224B |
| October 14, 2026 | 2.180B |
| October 13, 2026 | 2.152B |
| October 12, 2026 | 2.222B |
| October 09, 2026 | 2.341B |
| October 08, 2026 | 2.302B |
| October 07, 2026 | 2.286B |
| October 06, 2026 | 2.288B |
| October 05, 2026 | 2.320B |
| October 02, 2026 | 2.304B |
| October 01, 2026 | 2.300B |
| September 30, 2026 | 2.282B |
| September 29, 2026 | 2.284B |
| September 28, 2026 | 2.325B |
| September 25, 2026 | 2.398B |
| September 24, 2026 | 2.392B |
| September 23, 2026 | 2.353B |
| September 22, 2026 | 2.414B |
| September 21, 2026 | 2.447B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.442B |
| September 17, 2026 | 2.484B |
| September 16, 2026 | 2.453B |
| September 15, 2026 | 2.451B |
| September 14, 2026 | 2.414B |
| September 11, 2026 | 2.413B |
| September 10, 2026 | 2.389B |
| September 09, 2026 | 2.419B |
| September 08, 2026 | 2.445B |
| September 04, 2026 | 2.456B |
| September 03, 2026 | 2.433B |
| September 02, 2026 | 2.491B |
| September 01, 2026 | 2.397B |
| August 31, 2026 | 2.289B |
| August 28, 2026 | 2.279B |
| August 27, 2026 | 2.317B |
| August 26, 2026 | 2.305B |
| August 25, 2026 | 2.264B |
| August 24, 2026 | 2.238B |
| August 21, 2026 | 2.217B |
| August 20, 2026 | 2.213B |
| August 19, 2026 | 2.321B |
| August 18, 2026 | 2.257B |
| August 17, 2026 | 2.217B |
| August 14, 2026 | 2.216B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 3.800B |
| Pfizer Inc. | 171.14B |
| Bristol Myers Squibb Co. | 125.60B |
| Repligen Corp. | 9.984B |
| Johnson & Johnson | 635.02B |
Market Cap Related Metrics
| PE Ratio | 11.71 |
| PS Ratio | 2.211 |
| Price to Book Value | 2.102 |
| Price to Free Cash Flow | 6.322 |
| Price | 36.13 |
| Earnings Yield | 8.54% |
| Operating PE Ratio | 9.201 |
| Normalized PE Ratio | 11.71 |